We thus hypothesized that its function might be upregulated in rats with heart failure, a condition that severely challenges the lung's ability to maintain fluid balance. Heart failure was induced by left coronary artery ligation. Echocardiographic and cardiovascular hemodynamics confirmed its development at 16 wk postligation. At that time, alveolar fluid clearance was measured by an increase in protein concentration over 1 h of a 5% albumin solution instilled into the lungs. Baseline alveolar fluid clearance was similar in heart failure and age-matched control rats. Terbutaline was added to the instillate to determine whether heart failure rats responded to -adrenoceptor stimulation. Alveolar fluid clearance in heart failure rats was increased by 194% after terbutaline stimulation compared with a 153% increase by terbutaline in control rats. To determine the mechanisms responsible for this accelerated alveolar fluid clearance, we measured ion transporter expression (ENaC, Na-KATPase, CFTR). No significant upregulation was observed for these ion transporters in the heart failure rats. Lung morphology showed significant alveolar epithelial type II cell hyperplasia in heart failure rats. Thus, alveolar epithelial type II cell hyperplasia is the likely explanation for the increased terbutaline-stimulated alveolar fluid clearance in heart failure rats. These data provide evidence for previously unrecognized mechanisms that can protect against or hasten resolution of alveolar edema in heart failure. albumin; terbutaline APPROXIMATELY FIVE MILLION Americans are living with heart failure, with 400,000 new cases diagnosed annually (18). A major clinical problem in heart failure is the development of pulmonary venous (and consequently, pulmonary capillary) hypertension, which ultimately may lead to pulmonary edema and impaired blood oxygenation. Recent studies have demonstrated that excess pulmonary edema fluid is cleared from the alveoli secondary to active transepithelial Na transport (14, 31). The alveolar epithelium plays a critical role during pulmonary edema recovery by actively absorbing Na (14, 31). -adrenoceptor and dopamine receptor agonists increase Na transport and thus hasten the resolution of pulmonary edema (2, 6, 31). These observations have important clinical significance because they suggest that -adrenoceptor-or dopamine receptor-agonist therapy might help patients to recover more rapidly from pulmonary edema (2, 16).Lungs of heart failure patients undergo extensive remodeling (18,25,26), resulting in architectural changes such as pulmonary artery and vein wall thickening, pulmonary arteriole muscularization, and capillary endothelial and alveolar epithelial basement membrane thickening (18). Collectively, such remodeling results in increased alveolocapillary barrier thickness, correlating with reduced microvascular fluid and protein permeabilities (11,20,45). In addition to the aforementioned changes, alveolar epithelial type II cell proliferation may occur in these lungs (25,26). Hence, the hypot...